TrialCancer discovery2024

Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRASG12C-Mutated Metastatic Colorectal Cancer.

Rona Yaeger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.